Radiopharm Theranostics Limited (ASX:RAD)

Radiopharm Theranostics Revenue

In the fiscal year ending June 30, 2025, Radiopharm Theranostics had annual revenue of 12.51M AUD with 538.86% growth. Radiopharm Theranostics had revenue of 10.07M in the half year ending June 30, 2025, with 417.19% growth.

• Revenue: 12.51M
• Revenue Growth: +538.86%
• P/S Ratio: 6.52
• Revenue / Employee: 893.73K
• Employees: 14
• Market Cap: 81.52M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	12.51M	10.55M	538.86%
Jun 30, 2024	1.96M	-4.25M	-68.46%
Jun 30, 2023	6.21M	-	-
Jun 30, 2022	-	-	-
Jun 30, 2021	-	-	-